Insulet Corp. Company Profile (NASDAQ:PODD)

Analyst Ratings

Consensus Ratings for Insulet Corp. (NASDAQ:PODD) (?)
Ratings Breakdown: 6 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $37.55 (7.24% upside)

Analysts' Ratings History for Insulet Corp. (NASDAQ:PODD)
Show:
DateFirmActionRatingPrice TargetActions
7/20/2016Piper Jaffray Cos.Reiterated RatingOverweight$41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/20/2016WedbushReiterated RatingOutperform$44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2016BTIG ResearchInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Sterne Agee CRTReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016William BlairUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Feltl & Co.UpgradeHold -> Buy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Benchmark Co.UpgradeHold -> Buy$30.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Robert W. BairdLower Price TargetNeutral$35.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Cowen and CompanyBoost Price Target$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015Northland SecuritiesReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Morgan StanleyInitiated CoverageEqual -> Equal Weight$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015Leerink SwannReiterated RatingBuy$40.00 -> $44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015Jefferies GroupBoost Price TargetBuy$30.00 -> $39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2015JPMorgan Chase & Co.Boost Price TargetNeutral$26.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Oppenheimer Holdings Inc.Lower Price TargetMarket Perform$33.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014JMP SecuritiesReiterated RatingMarket Outperform$9.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2014Northcoast ResearchInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2014Off Wall StreetReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Insulet Corp. (NASDAQ:PODD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016Q216($0.17)$81.10 millionN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2016Q116($0.19)($0.19)$79.06 million$81.21 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415($0.26)($0.48)$91.89 million$100.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.26)($0.33)$83.56 million$87.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2015Q215($0.13)($0.27)$70.32 million$75.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115($0.10)($0.21)$68.20 million$61.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414($0.04)($0.10)$73.52 million$72.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.08)($0.06)$72.94 million$72.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.06)($0.11)$68.47 million$69.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.09)($0.04)$67.94 million$68.53 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.16)($0.39)$62.01 million$61.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013($0.19)($0.20)$60.47 million$60.09 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2013Q1 2013($0.21)($0.20)$57.26 million$57.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2013Q4 2012($0.21)($0.21)$59.12 million$57.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312($0.22)($0.26)$54.93 million$54.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2012($0.25)($0.30)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2012($0.28)($0.31)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2012($0.26)($0.30)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011($0.25)($0.29)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011($0.21)($0.42)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2011($0.22)($0.22)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/15/2011($0.26)($0.50)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Insulet Corp. (NASDAQ:PODD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.29)($0.29)($0.29)
Q2 20163($0.21)($0.14)($0.18)
Q3 20162($0.17)($0.15)($0.16)
Q4 20163($0.14)($0.08)($0.11)
Q1 20171($0.14)($0.14)($0.14)
Q2 20171($0.11)($0.11)($0.11)
Q3 20171($0.12)($0.12)($0.12)
Q4 20171($0.08)($0.08)($0.08)
Q1 20181$0.06$0.06$0.06
Q2 20181$0.10$0.10$0.10
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Insulet Corp. (NASDAQ:PODD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Insulet Corp. (NASDAQ:PODD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/25/2016Regina O SommerDirectorSell8,019$30.42$243,937.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Patrick J SullivanCEOBuy45,000$27.00$1,215,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Bradley A ThomasEVPBuy2,975$26.63$79,224.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2016Bradley A ThomasEVPBuy1,656$30.13$49,895.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Daniel J LevangieInsiderSell12,299$30.89$379,916.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Daniel J LevangieInsiderSell7,663$31.15$238,702.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2016Jessica HopfieldDirectorBuy3,230$30.91$99,839.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2015Patrick J SullivanCEOBuy10,000$29.39$293,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2015Patrick J SullivanCEOBuy20,000$27.91$558,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2015Timothy J ScannellDirectorBuy3,500$27.05$94,675.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2015Bradley A ThomasEVPBuy1,000$27.26$27,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2015Patrick RyanCOOBuy3,669$26.99$99,026.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2015R Anthony DiehlGeneral CounselSell3,372$30.96$104,397.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Patrick J SullivanCEOBuy10,000$31.93$319,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Charles T LiamosDirectorSell4,000$32.00$128,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2015Charles T LiamosDirectorSell4,000$32.00$128,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Charles T LiamosDirectorSell4,000$46.08$184,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Charles T LiamosDirectorSell4,000$42.95$171,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Charles T LiamosDirectorSell4,000$36.58$146,320.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014R Anthony DiehlGeneral CounselSell1,250$36.59$45,737.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Charles T LiamosDirectorSell4,000$35.17$140,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Duane DesistoCEOSell20,000$36.30$726,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Duane DesistoCEOSell20,000$34.23$684,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Duane DesistoCEOSell20,000$40.52$810,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014R Anthony DiehlGeneral CounselSell1,250$39.65$49,562.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2014R Anthony DiehlGeneral CounselSell17,871$37.09$662,835.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2014Peter DevlinInsiderSell12,314$37.10$456,849.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2014Peter DevlinInsiderSell30,000$41.25$1,237,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/3/2014R Anthony DiehlGeneral CounselSell4,617$48.67$224,709.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2014R Anthony DiehlGeneral CounselSell12,458$49.28$613,930.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2014Tracey Haas WielinskiVPSell8,275$49.21$407,212.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014Charles LiamosDirectorSell11,037$42.93$473,818.41View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014Duane DesistoCEOSell20,000$42.95$859,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014Peter DevlinInsiderSell30,000$42.82$1,284,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/3/2014Charles LiamosCOOSell86,000$36.02$3,097,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Duane DesistoCEOSell20,000$36.07$721,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2013Charles LiamosCOOSell63,808$36.26$2,313,678.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2013Charles LiamosCOOSell80,000$35.60$2,848,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Duane DesistoCEOSell20,000$33.38$667,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2013Sally CrawfordDirectorSell9,000$33.42$300,780.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013Regina SommerDirectorSell5,000$33.32$166,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Duane DesistoCEOSell20,000$31.85$637,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Duane DesistoCEOSell20,000$31.51$630,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Peter DevlinInsiderSell30,000$31.48$944,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2013Sally CrawfordDirectorSell31,000$30.47$944,570.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013R Anthony DiehlGeneral CounselSell38,455$30.50$1,172,877.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Duane DesistoCEOSell20,000$29.76$595,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2012Brian K RobertsCFOSell10,000$21.92$219,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2012Brian K RobertsCFOSell10,000$21.49$214,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012Brian K RobertsCFOSell10,000$20.78$207,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012Duane DesistoCEOSell20,000$20.97$419,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012Ruthann DepietroVPSell1,000$20.90$20,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Insulet Corp. (NASDAQ:PODD)
DateHeadline
07/26/16 06:15 PMCan Shares Of Insulet Corporation (NASDAQ:PODD) Hit $44? - Investor Newswire
07/26/16 06:15 PMPrice Target of $38.659 Set For Insulet Corporation (NASDAQ:PODD) - RealistInvestor.com
07/23/16 09:46 AMInsulet Corporation (NASDAQ:PODD) Short Interest Decreased By 1.6% - Consumer Eagle
07/21/16 06:11 PMEarnings Focus and Crowd Sourced Sentiment Review for Insulet Corporation (NASDAQ:PODD) - TGP
07/18/16 11:24 AMTracking Trading Performance for: Insulet Corporation (NASDAQ:PODD) - TGP
07/18/16 11:24 AMTrading Performance and Target Watch for Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/18/16 11:24 AMShare Performance Summary for: Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/17/16 05:20 PMTrading Focus on Shares of: Insulet Corporation (NASDAQ:PODD) - TGP
07/15/16 11:01 AMLarge Inflow of Money Detected in Insulet Corporation - TheFounders Daily
07/14/16 09:31 AMAnalyst Target and Average Rating Watch: Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/14/16 09:31 AMStrong Sell Calls For Insulet Corporation (NASDAQ:PODD) At 0 - Investor Newswire
07/14/16 09:31 AMInsiders Increasing Positions in: Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/14/16 09:31 AMInsulet Corporation (NASDAQ:PODD) Yearly Sales Target At $455.955 - Investor Newswire
07/13/16 05:23 AMInsulet Launches New Educational iPad App: Toby's T1D Tale - [at noodls] - Omnipod Mascot Provides Diabetes Education to Children and Caregivers through Stories, Tips and Trivia BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the ...
07/13/16 05:00 AMInsulet Launches New Educational iPad App: Toby’s T1D Tale - [Business Wire] - Insulet Corporation , the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System , today announced the introduction of a new educational app at the 17th annual Children with Diabetes "Friends for Life®" conference in Orlando, Florida.
07/12/16 10:17 AMTarget Tracker and Earnings View for Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/12/16 10:17 AMInsulet Corporation (NASDAQ:PODD) Updated Price Targets - FTSE News
07/12/16 10:17 AMInsulet Corporation (NASDAQ:PODD) Awarded Price Target of $38.659 - RealistInvestor.com
07/11/16 05:52 PMTrading Review - Company in Focus: Insulet Corporation (NASDAQ:PODD) - Telanagana Press
07/11/16 05:52 PMImpact Score and Stock Sentiment Outlook :Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/10/16 05:11 PMFocus Stock Trading Recap : Insulet Corporation (NASDAQ:PODD) - Telanagana Press
07/10/16 05:11 PMInsulet Corporation (NASDAQ:PODD): Check on Company Stock Performance - Press Telegraph
07/10/16 05:11 PMStock Performance Rundown on: Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/10/16 05:11 PMInsulet Corporation (NASDAQ:PODD) Broker Price Targets For The Coming Week - Fiscal Standard
07/08/16 05:54 PMNews Sentiment and Impact Score Review for :Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/08/16 08:47 AMInsulet Corporation (NASDAQ:PODD) Current Analyst Ratings - Fiscal Standard
07/07/16 05:56 PMEarnings Review and Price Target Watch for Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/07/16 05:56 PMInsulet Corporation (PODD) : Analyst Rating Update - Trade Calls
07/06/16 06:07 PMInsulet Corporation (NASDAQ:PODD) Earnings Check and Analyst Rating Update - Telanagana Press
07/06/16 06:07 PMInsulet Corporation to Announce Second Quarter 2016 Financial Results on August 3, 2016 - Yahoo Finance
07/06/16 04:01 PMInsulet Corporation to Announce Second Quarter 2016 Financial Results on August 3, 2016 - [at noodls] - BILLERICA, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod Insulin Management System, today announced ...
07/06/16 10:32 AMStock Tracking Down This Month; Investor Alert on Insulet Corporation (NASDAQ:PODD) - Engelwood Daily
07/06/16 10:32 AMWhich Way is Stock Sentiment Leaning on :Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/05/16 05:38 PMFocus Stock Performance Review : Insulet Corporation (NASDAQ:PODD) - Telanagana Press
07/05/16 05:38 PMInsulet Corporation (NASDAQ:PODD) Expected to Reach Highs Of $44 - Investor Newswire
07/03/16 05:12 PMInsulet Corporation (NASDAQ:PODD) Stock Focus and Earnings Glance - Telanagana Press
07/03/16 05:12 PMInsulet Corporation (NASDAQ:PODD) Impact Score and Stock Sentiment Recap - Press Telegraph
07/03/16 05:12 PMShare Performance Recap for: Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/03/16 10:04 AMInsulet Corporation (NASDAQ:PODD) Low Price Is Set At $34 - RealistInvestor.com
07/02/16 05:32 PMCheck on Earnings and Price Target Insulet Corporation (NASDAQ:PODD) - Press Telegraph
07/02/16 08:38 AMInsulet Corporation (NASDAQ:PODD) Sellers Covered 1.93% of Their Shorts - Engelwood Daily
07/02/16 08:38 AMAravt Global LLC Increased Insulet Corp (NASDAQ:PODD) by $22.77 Million as Shares Declined - Engelwood Daily
06/29/16 05:48 PMInsulet Corporation (NASDAQ:PODD) Earnings Review and Target Focus - Telanagana Press
06/28/16 10:45 AMInsulet Corporation (NASDAQ:PODD) Shorts Decreased by 1.93% After Short Covering - Engelwood Daily
06/28/16 10:45 AMTarget Price Consensus Focus on Insulet Corporation (NASDAQ:PODD) - Press Telegraph
06/25/16 05:21 PMInsulet : What Investors are Making of These Healthcare Stocks? - Antares Pharma, Globus Medical, NuVasive, and Insulet
06/17/16 04:08 PMINSULET CORP Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits -
06/16/16 06:08 PMStudies Find Omnipod System Effective in Controlling Blood Glucose Levels Among Patients With Diabetes
06/16/16 06:08 PMInsulet touts new data showing reduced A1c levels with Omnipod system | American Diabetes Assn. 2016 Scientific Sessions
06/13/16 05:25 PMMedtronic presents pivotal artificial pancreas data at ADA, as Insulet details its own plans

Social

About Insulet Corp.

Insulet Corp. logoInsulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The OmniPod System consists of the OmniPod, a small, self-adhesive disposable tubeless OmniPod device, which is worn on the body for approximately three days at a time and its wireless handheld Personal Diabetes Manager (PDM). The Company purchases OmniPods pursuant to its agreement with Flextronics. It also partners with pharmaceutical and biotechnology companies to tailor the OmniPod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas. It sells the OmniPod System and other diabetes management supplies in the United States through direct sales to customers or through its distribution partners. The Company purchases OmniPods pursuant to its agreement with Flextronics. The OmniPod System is available in Europe, Canada and Israel.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: PODD
  • CUSIP: 45784P10
Key Metrics:
  • Previous Close: $35.01
  • 50 Day Moving Average: $31.48
  • 200 Day Moving Average: $31.28
  • P/E Ratio: N/A
  • P/E Growth: -1.99
  • Market Cap: $2.00B
  • Beta: 1.34
  • Current Year EPS Consensus Estimate: $-0.6 EPS
  • Next Year EPS Consensus Estimate: $-0.35 EPS
Additional Links:
Insulet Corp. (NASDAQ:PODD) Chart for Friday, July, 29, 2016